Phase 2 Readout
LGVN: Phase 2 Readout: elpis ii
August 1, 2026 · elpis ii. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 1, 2026
- Company
- Longeveron Inc. (LGVN)
- Drug
- elpis ii
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout
Phase 2 Readout: elpis ii
- Company
- Longeveron Inc. (LGVN)
- Drug
- elpis ii
- Indication
- hypoplastic left heart syndrome (HLHS)